United States· US:71610-707_391af5b8-2992-47ad-80dd-9b5c373f7ce4
Divalproex Sodium
A valproic acid product containing divalproex sodium, registered in United States by Aphena Pharma Solutions - Tennessee, LLC. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Valproic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC N03AG01 (valproic acid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Valproic acid · ATC N03AG01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of valproic acid costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Valproic acid · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.61
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DIVALPROEX SODIUM
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Country
- United States (US)
- ATC code
- N03AG01
- ATC class
- Valproic acid
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1171610-707-70
- ndc1171610-707-80
- ndc11716107075360 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-707-53)
- ndc11716107076090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-707-60)
- ndc117161070770120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-707-70)
- ndc117161070780180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-707-80)
- ndc1171610-707-53
- ndc1171610-707-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
391 interactions on record for valproic acid.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valproic acid · interactions on record
391 records
- 9 severe
- 132 moderate
- 23 minor
- 189 info
Most severe, free to view
- Glycerol phenylbutyrateA16AX09severe
- BexaroteneL01XF03severe
- VorinostatL01XH01severe
- BexarotenL01XX25severe
38 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valproic acid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- France · Depakote, Divalcote
- United Kingdom (Northern Ireland) · Belvo, Depakote
- Croatia · Dipleksil
- Portugal · Diplexil-R, Valproato Semisódico Tecnifar
- Slovenia · Dipleksil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3f6fe03-a13d-4c1f-8bb4-90f92baa727d GET /v1/drugs/e3f6fe03-a13d-4c1f-8bb4-90f92baa727d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "500",
"substance": "DIVALPROEX SODIUM",
"productndc": "71610-707",
"dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA077567",
"marketing_category": "ANDA"
}See everything about valproic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.